Ribbon 3

    Pioneer the Possible With Nasdaq Biotech

    With disruption in our DNA, we are home to today’s biotech changemakers, trailblazers and titans, helping them pioneer a better tomorrow.

    Biotech and healthcare IPOs at Nasdaq

    Nasdaq Biotechnology Index

    Since 1993, the Nasdaq Biotechnology Index® (NBI) has tracked transformative biotechnology and pharmaceutical companies, becoming one of the largest and most representative benchmarks in the space. Driven by innovation, NBI (TM) continues to outperform the S&P 500 and Health Care Select Index.

    The Benchmark for Technology-Driven Healthcare Innovation

    biotech 2

    Invesco Nasdaq Biotechnology ETF

    Biotech is paving the way for a post-pandemic world. Through the Invesco Nasdaq Biotechnology ETF, access a high concentration of companies critical to COVID-19 vaccines and treatments, as well as the continued growth of genomics, wellness and advanced medical therapeutics.

    Investing in a Better Tomorrow

    Pillars of Possibilities

    Dynamic Unlocking Opportunity Icon

    Unlocking Opportunity

    We connect today's biotech trailblazers and titans with the capital they need to unlock opportunity and accelerate innovation that transforms lives.

    Dynamic Benchmarking Innovation Icon

    Benchmarking Innovation

    The Nasdaq Biotech Index has provided a benchmark for biotech innovation for more than 25 years.

    Dynamic Investing in Tomorrow Icon

    Investing in Tomorrow

    Learn how to invest in the Nasdaq Biotech Index and help accelerate the global impact of the companies who are changing the world.

    Jordan Saxe

    "We are the home to Biotech because we committed to the industry from the very beginning. Our gateway to the capital markets allows researchers, scientists and business leaders to pioneer the possible every day—and we are proud to be with them at every step of that journey."

    pioneer the possible

    Backing Biotech Since the Beginning

    We've backed biotech for 50 years and counting, providing the disruptors and innovators with a place to call home and access to the capital they need to propel their businesses forward.

    98%

     

    of U.S. Listed Biotech Companies are listed on Nasdaq

     

     

    Pioneering New Possibilities

    cell being injected with needle

    Moderna Announces FDA Authorization of Its COVID-19 Vaccine in U.S.

    In December 2020, Moderna COVID-19 Vaccine was authorized for distribution and use under an Emergency Use Authorization (EUA). Delivery to the U.S. Government began immediately.

    biotech 2

    Amgen Wins Approval for Pathbreaking Lung Cancer Drugs

    A potential blockbuster, this new drug is first to treat common cancer mutation called KRAS that researchers struggled for years to target.

    biotech

    BioNTech to roll out mRNA Production in Africa

    Pharmaceutical company BioNTech has announced plans to establish mRNA vaccine production facilities in Africa — part of a larger plan to combat diseases on the continent.

    "We are excited to expand our relationship with Nasdaq in order to offer investors another way to access innovative companies currently shaping the way we live and work."

    Biotech Abstract Image

    Nasdaq Junior Biotechnology Index

    With a greater emphasis on smaller, less mature companies, Nasdaq Junior Biotechnology Index (NBIJR) represents more of a pure play on biotech R&D.

    ETPs Tracking NBI

    Given the strength of the Nasdaq Biotech Index, numerous exchange-traded products are tracking the index. From Asia to North America and Europe to the Middle East, discover the global reach of NBI.

    Nasdaq Biotech Index Vs. Other Biotech Indexes

    Resource Center

    Invesco and Nasdaq Expand Partnership with Two New Thematic ETFs

    Nasdaq Biotech Index: A True Benchmark for Technology-Driven Healthcare Innovation

    Biotech in the Age of Coronavirus

    Deals and Data are the Heartbeat of Biotech

    The True Benchmark for Tech-Driven Innovation in Healthcare [WEBINAR]